BFRI (Biofrontera) Days Sales Outstanding : 37.01 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biofrontera Days Sales Outstanding?

Biofrontera's average Accounts Receivable for the three months ended in Dec. 2024 was $5.09 Mil. Biofrontera's Revenue for the three months ended in Dec. 2024 was $12.56 Mil. Hence, Biofrontera's Days Sales Outstanding for the three months ended in Dec. 2024 was 37.01.

The historical rank and industry rank for Biofrontera's Days Sales Outstanding or its related term are showing as below:

BFRI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.76 Med: 52.12 Max: 77.09
Current: 43.76

During the past 6 years, Biofrontera's highest Days Sales Outstanding was 77.09. The lowest was 43.76. And the median was 52.12.

BFRI's Days Sales Outstanding is ranked better than
79.37% of 960 companies
in the Drug Manufacturers industry
Industry Median: 72.25 vs BFRI: 43.76

Biofrontera's Days Sales Outstanding declined from Dec. 2023 (38.56) to Dec. 2024 (37.01).

Biofrontera Days Sales Outstanding Historical Data

The historical data trend for Biofrontera's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera Days Sales Outstanding Chart

Biofrontera Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

77.09

53.01

47.94

47.73

51.23

Biofrontera Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial														38.56	50.07	40.88	42.42	37.01

Competitive Comparison of Biofrontera's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Biofrontera's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofrontera's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofrontera's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Biofrontera's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Biofrontera Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Biofrontera's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (5.162	+	5.315)	/	2 )	/	37.321	*	365
=	5.2385					/	37.321	*	365
=	51.23

Biofrontera's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (4.874	+	5.315)	/	2 )	/	12.56	*	365 / 4
=	5.0945					/	12.56	*	365 / 4
=	37.01

Biofrontera (NAS:BFRI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Biofrontera Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Biofrontera's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofrontera Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera Inc (NAS:BFRI) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Presidential Way, Suite 330, Woburn, MA, USA, 01801

Website

https://www.biofrontera-us.com

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Executives

Heikki Lanckriet	director	C/O BIOFRONTERA INC., 120 PRESIDENTIAL WAY, SUITE 330, WOBURN MA 01801
Eugene Frederick Leffler	officer: Chief Financial Officer	84 BAY DRIVE, SUDBURY MA 01776
Kevin Daniel Weber	director	119 BUCHANAN COURT, CELINA TX 75009
Borer John J Iii	director	1270 AVENUE OF THE AMERICAS, 16TH FLOOR, NEW YORK NY 10020
Beth J. Hoffman	director	5895 BLAZING STAR LANE, SAN DIEGO CA 92130
Loretta M. Wedge	director	21260 WACISSA DRIVE, VENICE FL 34293
Ag Biofrontera	10 percent owner	HEMMELRATHER WEG 201, LEVERKUSEN 2M D-51377
Erica F. Gates	officer: Controller	C/O BIOFONTERA INC.,, 120 PRESIDENTIAL WAY, SUITE 330, WOBURN MA 01801
Erica L. Monaco	director, officer: Chief Financial Officer/COO	C/O BIOFONTERA INC.,, 120 PRESIDENTIAL WAY, SUITE 330, WOBURN MA 01801
Hermann Luebbert	director, officer: Chief Executive Officer	C/O BIOFONTERA INC.,, 120 PRESIDENTIAL WAY, SUITE 330, WOBURN MA 01801